$11.59
00.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Y-mAbs Therapeutics
YMABNASDAQ
Y-mAbs Therapeutics (YMAB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestY-mAbs Therapeutics (NASDAQ:YMAB) Stock Quotes, Forecast and News Summary
Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 347.19K |
| Day Range | - - - |
| 52 Wk Range | 4.60 - 20.90 |
| Market Cap | $508.60M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 9.84% |
| Days to Cover | 10.27 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Y-Mabs Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Y-mAbs Therapeutics (YMAB) stock?
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Who are Y-mAbs Therapeutics (YMAB) competitors?
Other companies in Y-mAbs Therapeutics’s space includes: Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), PepGen (NASDAQ:PEPG), Altimmune (NASDAQ:ALT) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Y-mAbs Therapeutics (YMAB) stock?
There is no analysis for Y-mAbs Therapeutics.
What is the forecast for Y-mAbs Therapeutics (YMAB) stock?
Y-mAbs Therapeutics has a consensus price target of $17.73.
Current stock price for Y-mAbs Therapeutics (YMAB)?
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $11.59 last updated July 19, 2024 at 4:00 PM EDT.
Does Y-mAbs Therapeutics (YMAB) pay a dividend?
There are no upcoming dividends for Y-mAbs Therapeutics.
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
Y-mAbs Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Y-mAbs Therapeutics (YMAB) going to split?
There is no upcoming split for Y-mAbs Therapeutics.
What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.